•
Dec 31, 2024

Amcor Q2 2025 Earnings Report

Reported a solid second quarter result with further sequential improvement in year over year volume growth and margins expansion.

Key Takeaways

Amcor reported net sales of $3,241 million and GAAP net income of $163 million for the December 2024 quarter. Adjusted EBIT increased by 5% on a comparable constant currency basis, reaching $363 million, and adjusted EPS also grew by 5% to 16.1 cents per share. The company reaffirmed its fiscal year 2025 outlook and announced a combination with Berry Global.

Further sequential improvement in year over year volume growth.

Net sales of $3,241 million.

GAAP Net income of $163 million; GAAP diluted earnings per share (EPS) of 11.3 cps.

Adjusted EBIT of $363 million, up 5% on a comparable constant currency basis.

Total Revenue
$3.24B
Previous year: $3.25B
-0.3%
EPS
$0.161
Previous year: $0.157
+2.5%
Gross Profit
-$6.05B
Previous year: $621M
-1073.8%
Cash and Equivalents
$445M
Previous year: $430M
+3.5%
Free Cash Flow
$330M
Previous year: $279M
+18.3%
Total Assets
$16.2B
Previous year: $16.7B
-3.4%

Amcor

Amcor

Amcor Revenue by Segment

Forward Guidance

Amcor reaffirmed its fiscal 2025 outlook, expecting adjusted EPS of 72-76 cents per share and adjusted free cash flow of $900-1,000 million.

Positive Outlook

  • Adjusted EPS of approximately 72 to 76 cents per share, which represents comparable constant currency growth of 3% to 8% compared with 70.2 cents per share in fiscal 2024.
  • Movements in exchange rates are not expected to have a material impact on reported EPS.
  • Adjusted Free Cash Flow of approximately $900 million to $1,000 million.
  • Delivering fourth consecutive quarter of sequential volume improvement.
  • Combination with Berry Global to significantly enhance value for our customers and shareholders

Challenges Ahead

  • Normalization of incentive compensation payments represents approximately 4% headwind.
  • Consumer and customer demand remained soft and variable in the North America beverage business
  • Destocking continued in healthcare
  • Price/mix had an unfavorable impact of approximately 2% primarily due to lower volumes in high value healthcare categories.
  • Volumes were broadly in line with last year in Latin America.

Revenue & Expenses

Visualization of income flow from segment revenue to net income